Literature DB >> 17975511

High incidence of malignant transformation of laryngeal papilloma in Taiwan.

Li-Ang Lee1, Ann-Joy Cheng, Tuan-Jen Fang, Chung-Guei Huang, Chun-Ta Liao, Joseph Tung-Chieh Chang, Hsueh-Yu Li.   

Abstract

OBJECTIVES: Papillomas of the larynx include solitary laryngeal papilloma and recurrent respiratory papillomatosis. This study investigated the incidence of malignant transformation and assessed possible risk factors for laryngeal papillomas. STUDY
DESIGN: A prospective, longitudinal study.
METHODS: Twenty-six consecutive laryngeal papilloma patients were prospectively studied for 5 or more years, and each patient was periodically examined at 3 to 6 month intervals. A detailed epidemiologic questionnaire was administered at the initial visit. After enrollment, tissue obtained during each laryngeal surgery was examined by polymerase chain reaction assay for human papilloma virus (HPV) and typing.
RESULTS: During 237 person-years of follow-up, six new, pathologically confirmed cases of laryngeal carcinoma were ascertained (incidence 2.5/100 person-years), and all were associated with HPV-6 or HPV-11. Malignant transformation revealed no correlation with the following: age less than 3 years at diagnosis, sex, history of tobacco use, history of alcohol consumption, family history of laryngeal cancer, or type of laryngeal papilloma. Laryngeal papilloma without demonstrable HPV DNA was the only significant risk factor for malignant transformation (P < .05). The cumulative risk of malignant transformation in subjects without demonstrable HPV DNA was significantly higher than that in HPV-positive patients (relative risk, 8.0; 95% confidence interval, 1.1-60.3; P = .05).
CONCLUSIONS: A relatively high incidence of malignant transformation of laryngeal papilloma was noted in Taiwanese patients. Patients without demonstrable HPV DNA require more frequent follow-up and may benefit from anti-HPV vaccinations.

Entities:  

Mesh:

Year:  2008        PMID: 17975511     DOI: 10.1097/MLG.0b013e318155a288

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

2.  A case of video-assisted thoracoscopic resection of malignant transformation of pulmonary recurrent respiratory papillomatosis.

Authors:  Dana A Dominguez; David T Martin; Jeffrey B Velotta
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

Review 3.  Recurrent respiratory papillomatosis: an overview.

Authors:  Qingliang Xue; Haitao Wang; Jianxin Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-28       Impact factor: 3.267

4.  Real-time in vivo diagnosis of laryngeal carcinoma with rapid fiber-optic Raman spectroscopy.

Authors:  Kan Lin; Wei Zheng; Chwee Ming Lim; Zhiwei Huang
Journal:  Biomed Opt Express       Date:  2016-08-26       Impact factor: 3.732

5.  Genomic differences in the background of different severity in juvenile-onset respiratory papillomatoses associated with human papillomavirus type 11.

Authors:  Tamás Gáll; Andrea Kis; Tímea Zsófia Tatár; Gábor Kardos; Lajos Gergely; Krisztina Szarka
Journal:  Med Microbiol Immunol       Date:  2013-05-07       Impact factor: 3.402

Review 6.  Immunological tolerance of low-risk HPV in recurrent respiratory papillomatosis.

Authors:  R Ivancic; H Iqbal; B deSilva; Q Pan; L Matrka
Journal:  Clin Exp Immunol       Date:  2019-10-31       Impact factor: 4.330

7.  Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two Cases.

Authors:  Armando Bedoya; Kristen Glisinski; Jeffrey Clarke; Richard N Lind; Charles Edward Buckley; Scott Shofer
Journal:  Am J Case Rep       Date:  2017-07-31

8.  Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in the northwest region of the Philippines.

Authors:  Pia Marie Albano; Dana Holzinger; Christianne Salvador; Jose Orosa; Sheryl Racelis; Modesty Leaño; Danilo Sanchez; Lara Mae Angeles; Gordana Halec; Markus Schmitt; John Donnie Ramos; Michael Pawlita
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

9.  Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia.

Authors:  Turid Omland; Kathrine A Lie; Harriet Akre; Lars Erik Sandlie; Peter Jebsen; Leiv Sandvik; Dag Andre Nymoen; Davit Bzhalava; Joakim Dillner; Kjell Brøndbo
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.